Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion type Assertion NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_head.
- NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_provenance.
- NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion evidence source_evidence_literature NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_provenance.
- NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion SIO_000772 25468223 NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_provenance.
- NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion wasDerivedFrom befree-2016 NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_provenance.
- NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion wasGeneratedBy ECO_0000203 NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_provenance.